Business Context and Reporting Period
This Form 8-K filing by Ingersoll Rand Inc. (IR) was submitted on August 20, 2024. The report details Item 5.02, concerning the appointment of certain officers and compensatory arrangements. Specifically, the Compensation Committee granted supplemental equity awards to two named executive officers following a mid-year compensation review.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on executive compensation adjustments. The only financial data point provided is the stock price used to determine the exercise price for new stock options.
- Stock Price (August 20, 2024): $90.50 per share (closing price).
- Option Exercise Price: $90.50 per share.
Material Changes
The material change reported is the grant of supplemental long-term incentive awards to two executives to ensure market competitiveness of total compensation:
- Vikram Kini (SVP and CFO): Granted 3,591 Restricted Stock Units (RSUs) and 8,694 stock options.
- Michael Weatherred (SVP, IR Execution Excellence): Granted 3,867 RSUs and 9,363 stock options.
These awards supplement the previously reported 2024 annual grants and are governed by the Amended and Restated 2017 Omnibus Incentive Plan.
Guidance, Outlook, and Risks
The filing contains standard forward-looking statements regarding the intent to align executive compensation with long-term value creation and stock performance. It includes a disclaimer that actual results may differ materially from expectations due to risks detailed in the company's most recent Form 10-K. No specific operational guidance or new risk factors were introduced in this document.
Investor Verification Checklist
- Verify the vesting schedule: Awards vest in four equal annual installments beginning August 20, 2025.
- Confirm the total number of shares potentially issuable: 12,285 RSUs and 18,057 stock options across both executives.
- Review the company's most recent Form 10-K for the full list of risk factors referenced in the forward-looking statements.
- Note that the value of these supplemental awards is expected to be incorporated into future annual grant cycles for these executives.